0000939767-20-000160.txt : 20201222
0000939767-20-000160.hdr.sgml : 20201222
20201222195831
ACCESSION NUMBER: 0000939767-20-000160
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201218
FILED AS OF DATE: 20201222
DATE AS OF CHANGE: 20201222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lamb Peter
CENTRAL INDEX KEY: 0001387306
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 201409481
MAIL ADDRESS:
STREET 1: PO BOX 511, 170 HARBOR WAY
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94083-0511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0101
BUSINESS ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wf-form4_160868509495790.xml
FORM 4
X0306
4
2020-12-18
0
0000939767
EXELIXIS, INC.
EXEL
0001387306
Lamb Peter
C/O EXELIXIS, INC.
1851 HARBOR BAY PARKWAY
ALAMEDA
CA
94502
0
1
0
0
EVP, Scientific Strategy & CSO
Common Stock
2020-12-18
4
M
0
65000
1.70
A
348124
D
Common Stock
2020-12-18
4
S
0
65000
20.01
D
283124
D
Common Stock
17105
I
By 401(k)
Option (right to buy)
1.7
2020-12-18
4
M
0
65000
0
D
2015-07-20
2021-09-18
Common Stock
65000.0
255000
D
Includes 132,872 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2020.
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.80 to $20.43. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of December 17, 2020.
The option, representing the right to purchase a total of 400,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016.
/s/ Jennifer Drimmer Rokovich, Attorney in Fact
2020-12-22